Sign up to save your podcasts
Or
Share BTK Inhibitors in Multiple Sclerosis Treatment
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
BTK Inhibitors in Multiple Sclerosis Treatment
Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis.
Read the related article on Tolebrutinib versus Teriflunomide in The New England Journal of Medicine.
Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
View all episodes
By American Academy of Neurology
4.7
272272 ratings
Dr. Justin Abbatemarco talks with Dr. Jiwon Oh about Bruton Tyrosine Kinase (BTK) Inhibitors and the recent data on tolebrutinib in multiple sclerosis.
Read the related article on Tolebrutinib versus Teriflunomide in The New England Journal of Medicine.
Read the related article on Tolebrutinib in Nonrelapsing Secondary Progressive MS in The New England Journal of Medicine.
Disclosures can be found at Neurology.org.
More shows like Neurology® Podcast
View all
JAMA Editors' Summary
129 Listeners
NEJM This Week
317 Listeners
Practical Neurology Podcast
34 Listeners
JAMA Clinical Reviews
480 Listeners
The Curbsiders Internal Medicine Podcast
3,335 Listeners
JAMA Neurology Author Interviews
14 Listeners
Core IM | Internal Medicine Podcast
1,096 Listeners
Neurology Today in 5
22 Listeners
Annals On Call Podcast
180 Listeners
The Clinical Problem Solvers
510 Listeners
Neurology Minute
131 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
321 Listeners
Neurology Exam Prep Podcast
178 Listeners
The Curious Clinicians
362 Listeners
Continuum Audio
73 Listeners